Press Release

Cephalosporin Drugs Market Trends 2019 – Competitive Analysis by Demand Status, Valuable Insights of Business, Product Scope, Driving Factors Forecast to 2024

Cephalosporin

The “Cephalosporin Drugs Market” report 2019 covers all the significant developments which are recently being adopted across the global market. The prime objective of Cephalosporin Drugs market report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. The Cephalosporin Drugs market report covers both the demand and supply aspect of the market. The report also highlighted the future trends in the Cephalosporin Drugs market that will impact the demand during the forecast period.

Scope of the Report:

  • As per the scope of this report, cephalosporins are part of the beta-lactams group and work by interfering with the synthesis of the bacterial cell wall. Some may be given orally, but most are given by injection. They are typically the second choice antibiotic, their main uses are in pneumonia, septicemia, meningitis, sinusitis, and UTIs treatment. Despite their second-line usage, cephalosporins have a broader spectrum of activity and are more potent than penicillin.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245334

    Market Overview:

  • – The major factors for the growth of the cephalosporin drugs market include the rising demand for anti-microbial in various indications, rising prevalence of infectious diseases, and increasing use of combination therapies.
  • – Most of the small companies out-license the products after taking them through the early clinical development phase. These agreements usually include one-time payment for obtaining the rights, in addition to the milestone payments on completing designated developmental phase and royalties on sales. There are over 50 cephalosporin drugs that have been approved in the past five decades, and almost half of them are for the antibacterial activity. However, new cephalosporins (classified as the fifth-generation), which are used for the treatment of serious gram-negative bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA), were recently approved.
  • – Manufacturers are involved in the development of new drugs to fight against anti-microbial resistance. The complexity and diversity of resistance mechanisms have defined the need for new and improved ?-lactam antibiotics. Additionally, the companies are involved in the strategic development of new products, for example, in 2017, Shionogi & Co. Ltd collaborated with the F. Hoffmann-La Roche Ltd for the development and commercialization of baloxavir marboxi.
  • – Thus, owing to the all above-mentioned factors the cephalosporin drugs market is expected to witness high growth over the forecast per

    Some of the Top Key Players of Cephalosporin Drugs Market Report Are:

  • Aristo Pharmaceuticals Ltd
  • Baxter International
  • F. Hoffmann
  • La Roche AG
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd
  • Mankind Pharma
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/14245334

    Key Market Trends:

    The Fifth-generation Segment is Expected to Account for the Largest Market Share During the Forecast Period

    The fifth-generation cephalosporins were developed in the lab to specifically target resistant strains of bacteria. In particular, ceftobiprole is effective against methicillin-resistant staphylococcus aureus (MRSA). These agents are sometimes referred to as the advanced generation, rather than fifth-generation cephalosporins. Cephalosporins exhibit side effects similar to penicillin, and drug-allergy and hypersensitivity. Cephalosporins, in general, have been associated with little hepatotoxicity and rare instances of drug-induced liver injury. The fifth-generation cephalosporins include Ceftobiprole, Ceftaroline, and Ceftolozane. Ceftobiprole has powerful antipseudomonal characteristics and appears to be less susceptible to the development of resistance. Ceftaroline has also been described as the fifth-generation cephalosporin, but does not have the antipseudomonal or VRE coverage of ceftobiprole. The market for Ceftolozane is growing at a good pace, as it has opened gates for an alternative for the treatment of complicated intra-abdominal infections (CIAI) and complicated urinary tract infections (CUTI). Furthermore, Ceftolozane is combined with the ?-lactamase inhibitor tazobactam, as multi-drug resistant bacterial infections generally exhibit resistance to all ?-lactam antibiotics, unless this enzyme is inhibited. Hence, the increase in the use of combination therapies is expected to drive the market during the forecast period.

    Asia-Pacific is Expected to be the Fastest Growing Segment in the Global Market

    Asia-Pacific is expected to dominate this market, due to the high prevalence of infectious diseases, increasing healthcare expenditure, and a large population base. Furthermore, the demand for better healthcare infrastructure and government initiatives is expected to help the growth of the market in this region. As per the statistics published by the World Health Organization (WHO) TB statistics for India for 2016, an estimated incidence of tuberculosis (TB) is 2.79 million cases in India. Thus, rising cases of various infections are expected to boost the overall growth of the market. Asia-Pacific is followed by Europe, due to its large base of geriatric population and rising prevalence of infectious diseases in several countries of the region.

    The Report Covers:

    • Comprehensive research methodology of Cephalosporin Drugs market
    • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
    • Analysis of regional regulations and other government policies impacting the global sleep aid market
    • Insights about market determinants which are stimulating the global Cephalosporin Drugs market
    • Detailed and extensive market segments with regional distribution of forecasted revenues
    • Extensive profiles and recent developments of market players Companies Mentioned

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245334

    Detailed TOC of Cephalosporin Drugs Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Demand for Anti-microbials in Various Indications
    4.2.2 Rising Prevalence of Infectious Diseases
    4.2.3 Increasing Use of Combination Therapies
    4.3 Market Restraints
    4.3.1 Stringent Regulatory Guidelines
    4.3.2 Weak Pipeline Molecules
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Generation
    5.1.1 First-generation
    5.1.2 Second-generation
    5.1.3 Third-generation
    5.1.4 Fourth-generation
    5.1.5 Fifth-generation
    5.2 By Prescription Type
    5.2.1 Prescription Drugs
    5.2.2 OTC Drugs
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Aristo Pharmaceuticals Ltd
    6.1.2 Baxter International
    6.1.3 F. Hoffmann-La Roche AG
    6.1.4 GlaxoSmithKline PLC
    6.1.5 Lupin Pharmaceuticals Inc.
    6.1.6 Macleods Pharmaceuticals Ltd
    6.1.7 Mankind Pharma
    6.1.8 Merck & Co. Inc.
    6.1.9 Pfizer Inc.
    6.1.10 Teva Pharmaceutical Industries Ltd

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Human Microbiome Market Size, share 2019-Global Business Trends, Share, Progress Insight, Modest Analysis, Statistics, Regional Demands, And Forecast to 2024

    Balancing Machines Market Size & Share 2019 – Review, Key Findings, Company Profiles, Complete Analysis, Growth Strategy, Developing Technologies, Trends and Forecast by Regions

    Subsea Production Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2019–2022

    Global Lighted Blanket Market Research Report 2019-2024 | Market Share, Size, and Revenue by Types, Applications, and Regional Forecast

    Tags
  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Close